Literature DB >> 8852056

Identification of 3-nitro-L-tyrosine, a product of nitric oxide and superoxide, as an indicator of oxidative stress in the human brain.

W Maruyama1, Y Hashizume, K Matsubara, M Naoi.   

Abstract

3-Nitro-L-tyrosine synthesized from L-tyrosine by peroxynitrite, a product of superoxide and nitric oxide, was identified for the first time in human brains. By quantitative analysis using high-performance liquid chromatography with multi-electrochemical detectors, 3-nitro-L-tyrosine concentration in the gray matter was higher in the cerebrum than in the cerebellum; 0.96 and 0.29 nmol/g wet weight, respectively. On the other hand, L-tyrosine concentration was not different. 3-Nitro-L-tyrosine in the brain may be used as an indicator of oxidative stress induced by reactive oxygen species and nitric oxide.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8852056     DOI: 10.1016/0378-4347(95)00400-9

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Appl        ISSN: 1572-6495


  10 in total

1.  The relationship between taurine and 3-nitrotyrosine level of hepatocytes in experimental endotoxemia.

Authors:  Hüsamettin Erdamar; Nurten Türközkan; Barboros Balabanli; Gonca Ozan; Filiz Sezen Bircan
Journal:  Neurochem Res       Date:  2007-06-15       Impact factor: 3.996

2.  Effects of taurine on nitric oxide and 3-nitrotyrosine levels in spleen during endotoxemia.

Authors:  Filiz Sezen Bircan; Barbaros Balabanli; Nurten Turkozkan; Gonca Ozan
Journal:  Neurochem Res       Date:  2011-06-15       Impact factor: 3.996

3.  Role of nitric oxide and peroxynitrite in the cytokine-induced sustained myocardial dysfunction in dogs in vivo.

Authors:  J i Oyama; H Shimokawa; H Momii; X Cheng; N Fukuyama; Y Arai; K Egashira; H Nakazawa; A Takeshita
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

4.  Effect of taurine on brain 8-hydroxydeoxyguanosine and 3-nitrotyrosine levels in endotoxemia.

Authors:  Gonca Ozan; Nurten Turkozkan; Filiz Sezen Bircan; Barbaros Balabanli
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

5.  Three months of moderate-intensity exercise reduced plasma 3-nitrotyrosine in rheumatoid arthritis patients.

Authors:  Alex J Wadley; Jet J C S Veldhuijzen van Zanten; Antonios Stavropoulos-Kalinoglou; George S Metsios; Jacqueline P Smith; George D Kitas; Sarah Aldred
Journal:  Eur J Appl Physiol       Date:  2014-04-10       Impact factor: 3.078

6.  Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation.

Authors:  K Hensley; M L Maidt; Z Yu; H Sang; W R Markesbery; R A Floyd
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

Review 7.  Protein 3-nitrotyrosine in complex biological samples: quantification by high-pressure liquid chromatography/electrochemical detection and emergence of proteomic approaches for unbiased identification of modification sites.

Authors:  Tal Nuriel; Ruba S Deeb; David P Hajjar; Steven S Gross
Journal:  Methods Enzymol       Date:  2008       Impact factor: 1.600

8.  Mitochondrial deficits and abnormal mitochondrial retrograde axonal transport play a role in the pathogenesis of mutant Hsp27-induced Charcot Marie Tooth Disease.

Authors:  Bernadett Kalmar; Amy Innes; Klaus Wanisch; Alicia Koyen Kolaszynska; Amelie Pandraud; Gavin Kelly; Andrey Y Abramov; Mary M Reilly; Giampietro Schiavo; Linda Greensmith
Journal:  Hum Mol Genet       Date:  2017-09-01       Impact factor: 6.150

9.  Development of an Analytical Assay for Electrochemical Detection and Quantification of Protein-Bound 3-Nitrotyrosine in Biological Samples and Comparison with Classical, Antibody-Based Methods.

Authors:  Ksenija Vujacic-Mirski; Kai Bruns; Sanela Kalinovic; Matthias Oelze; Swenja Kröller-Schön; Sebastian Steven; Milos Mojovic; Bato Korac; Thomas Münzel; Andreas Daiber
Journal:  Antioxidants (Basel)       Date:  2020-05-06

10.  Nitric oxide function in atherosclerosis.

Authors:  K E Matthys; H Bult
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.